TrialBlood advances2025
Camidanlumab tesirine for relapsed or refractory classic Hodgkin lymphoma: a phase 2 study.
Alex F Herrera et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
5 papers cite it
this papercites it
TrialBlood advances2025
Alex F Herrera et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.